Author(s):
Aseem Kumar, Anil Kumar Sharma, Rohit Dutt
Email(s):
aseemkumar1984@gmail.com
DOI:
10.5958/0974-360X.2021.00098.6 
Address:
Aseem Kumar*, Anil Kumar Sharma, Rohit Dutt
School of Medical and Allied Sciences (SoMAS), G. D. Goenka University, Sohna Road, Gurugram, Haryana, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 1,
Year - 2021
ABSTRACT:
The present review provides concise information on status of gastro-retentive drug delivery systems for antidiabetic molecules. Present review emphasis on pharmacotherapy of diabetes via gastric retention of drug molecules. The gastro-retentive system is a proven useful tool for sustaining the drug release for the drugs having good absorption through the GIT, drugs with narrow therapeutic index and low dose drugs. The gastro-retentive dosage forms have also been developed for antidiabetic molecules and metformin hydrochloride, the first line drug in the treatment of diabetes is commercially available in the market in the form of sustained release formulations. As oral antidiabetic therapy is required for prolonged duration, the oral hypoglycemic may lead to side effects such as diabetic neuropathy, diabetic myopathy and many more. The primary reason for side effects is under-utilization of the drug molecule which can be improved using gastro-retentive drug delivery systems thereby minimizing the side effects. Despite being one of the most successfully systems, the commercial value gastro-retentive drug delivery systems is still below par. Gastro-retentive drug delivery systems for antidiabetic drug molecules are still awaited. The research is still in progress for gastro-retentive formulations which can attract industry utilizing these systems for humanely causes.
Cite this article:
Aseem Kumar, Anil Kumar Sharma, Rohit Dutt. A Review of Gastro-retentive Drug Delivery Systems for Antidiabetics and its present status. Research J. Pharm. and Tech. 2021; 14(1):538-546. doi: 10.5958/0974-360X.2021.00098.6
Cite(Electronic):
Aseem Kumar, Anil Kumar Sharma, Rohit Dutt. A Review of Gastro-retentive Drug Delivery Systems for Antidiabetics and its present status. Research J. Pharm. and Tech. 2021; 14(1):538-546. doi: 10.5958/0974-360X.2021.00098.6 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-1-98
REFERENCES:
1. Pinto JF. Site-specific drug delivery systems within the gastro-intestinal tract: From the mouth to the colon. International Journal of Pharmaceutics. 2010;395(1-2):44–52.
2. Rouge N, Buri P, Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. International Journal of Pharmaceutics. 1996;136(1-2):117–39.
3. Kagan L, Hoffman A. Selection of drug candidates for gastroretentive dosage forms: Pharmacokinetics following continuous intragastric mode of administration in a rat model. European Journal of Pharmaceutics and Biopharmaceutics. 2008; 69(1):238–46.
4. Boldhane S, Kuchekar B. Development and optimization of metoprolol succinate gastroretentive drug delivery system. Acta Pharmaceutica. 2010;60 (4):415–25.
5. Garg R, Gupta G. Progress in Controlled Gastroretentive Delivery Systems. Tropical Journal of Pharmaceutical Research. 2008;7(3): 1055–1066.
6. Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: A review. AAPS Pharm Sci Tech. 2005;6(3): E372–90.
7. Goddard AF, Logan RPH. Diagnostic methods for Helicobacter pylori detection and eradication. British Journal of Clinical Pharmacology. 2003;56(3):273–83.
8. Coupe A, Davis S, Evans D, Wilding I. Do pellet formulations empty from the stomach with food? International Journal of Pharmaceutics. 1993;92(1-3):167–75.
9. Beten D, Gansbeke BV, Schoutens A, Moës A. Evaluation of the gastric behaviour of coevaporate particles under fasting and non-fasting conditions. International Journal of Pharmaceutics. 1995;123(1):145–7.
10. Rouge N, Buri P, Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. International Journal of Pharmaceutics. 1996;136(1-2):117–39.
11. Weitschies W, Kosch O, Monnikes H, Trahms L. Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Advanced Drug Delivery Reviews. 2005;57(8):1210–22.
12. Jain SK, Agrawal GP, Jain NK. A novel calcium silicate based microspheres of repaglinide: In vivo investigations. Journal of Controlled Release. 2006;113(2):111–6.
13. Mandal UK, Chatterjee B, Senjoti FG. Gastro-retentive drug delivery systems and their in vivo success: A recent update. Asian Journal of Pharmaceutical Sciences. 2016;11(5):575–84.
14. Patel A, Modasiya M, Shah D, Patel V. Development and In Vivo Floating Behavior of Verapamil HCl Intragastric Floating Tablets. AAPS PharmSciTech. 2009;10(1):310–5.
15. Bolondi L, Bortolotti M, Santi V, Calletti T, Gaiani S, Labò G. Measurement of gastric emptying time by real-time ultrasonography. Gastroenterology. 1985;89(4):752–9.
16. Weitschies W, Kötitz R, Cordini D, Trahms L. High-Resolution Monitoring of the Gastrointestinal Transit of a Magnetically Marked Capsule. Journal of Pharmaceutical Sciences. 1997;86(11):1218–22.
17. Moini J. Pathophysiology of Diabetes. Epidemiology of Diabetes. Amsterdam: Elsevier; 2019. pp. 25–43.
18. Shaw J, Sicree R, Zimmet P. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice. 2010;87(1):4–14.
19. Washington N, Washington C, Wilson CG, Wilson CG. Physiological pharmaceutics: barriers to drug absorption. New York: Taylor and Francis; 2001.pp 60-70.
20. Singh B. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. Journal of Controlled Release. 2000;63(3):235–59.
21. Sungthongjeen S, Paeratakul O, Limmatvapirat S, Puttipipatkhachorn S. Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique. International Journal of Pharmaceutics. 2006;324(2):136–43.
22. Vidon N, Chaussade S, Noel M, Franchisseur C, Huchet B, Bernier J. Metformin in the digestive tract. Diabetes Research and Clinical Practice. 1988;4(3):223–9.
23. Marathe PH, Wen Y, Norton J, Greene DS, Barbhaiya RH, Wilding IR. Effect of altered gastric emptying and gastrointestinal motility on metformin absorption. British Journal of Clinical Pharmacology. 2001;50(4):325–32.
24. Stepensky D, Friedman M, Srour W, Raz I, Hoffman A. Preclinical evaluation of pharmacokinetic–pharmacodynamic rationale for oral CR metformin formulation. Journal of Controlled Release. 2001;71(1):107–15.
25. Dube T, Ranpise N, Ranade A. Formulation and Evaluation of Gastroretentive Microballoons Containing Baclofen for a Floating Oral Controlled Drug Delivery System. Current Drug Delivery. 2014;11(6):805–16.
26. Iannuccelli V, Coppi G, Bernabei M, Cameroni R. Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. International Journal of Pharmaceutics. 1998;174(1-2):47–54.
27. Açikgöz M, Kaş HS, Hasçelik Z, Milli U, Hincal AA. Chitosan microspheres of diclofenac sodium, II: In vitro and in vivo evaluation. Die Pharmazie. 1995;50(4):275-277.
28. Patel AS, Roy SS, Thakur RS. Invitro evaluation and optimization of controlled release Floating Drug Delivery System of metformin hydrochloride. DARU-Journal of faculty of pharmacy. 2006;14(2:57–64.
29. Sharma M, Kohli S, Dinda A. In-vitro and in-vivo evaluation of repaglinide loaded floating microspheres prepared from different viscosity grades of HPMC polymer. Saudi Pharmaceutical Journal. 2015;23(6):675–82.
30. Kamila MM, Mondal NK, Ghosh LK, Gupta Bundefined. Multiunit Floating Drug Delivery System of Rosiglitazone Maleate: Development, Characterization, Statistical Optimization of Drug Release and In Vivo Evaluation. AAPS PharmSciTech. 2009;10(3): 887–99
31. Thulluru A, Varma MM, Setty CM, Anusha A, Chamundeeswari P, Sanufar S. Formulation, in vitro and in vivo evaluation of pioglitazone hydrochloride - Effervescent gastro retentive floating hydrophilic matrix tablets. International Journal of PharmTech Research. 2016;9(7):388–98.
32. Ahmed MG, Sanjana A, Rajeev V. Design and optimization of gastroretentive drug delivery system of sitagliptin. International Journal of Pharmaceutical Sciences and Research. 7(5):2187–93.
33. Jeganath S, Shafiq KM, Mahesh PG, S SK. Formulation and evaluation of non-effervescent floating tablets of linagliptin using low-density carriers. Drug Invention Today. 2018;10(3):322–9.
34. Duggi S, Narendra Chary T . Studies on formulation development of gastroretentive drug delivery system for pioglitazone hydrochloride. International Journal of Pharmacy. 2014;4(3): 241–54 .
35. Mahmoud DBED, Shukr MH, Elmeshad AN. Gastroretentive Microsponge as a Promising Tool for Prolonging the Release of Mitiglinide Calcium in Type-2 Diabetes Mellitus: Optimization and Pharmacokinetics Study. AAPS PharmSciTech. 2018;19(6):2519–32.
36. Bardonnet P, Faivre V, Pugh W, Piffaretti J, Falson F. Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. Journal of Controlled Release. 2006;111(1-2):1–18.
37. Boldhane S, Kuchekar B. Gastroretentive Drug Delivery of Metformin Hydrochloride: Formulation and In Vitro Evaluation Using 32 Full Factorial Design. Current Drug Delivery. 2009;6(5):477–85.
38. Ahuja A, Khar RK, Ali J. Mucoadhesive Drug Delivery Systems. Drug Development and Industrial Pharmacy. 1997;23(5):489–515.
39. Park K, Robinson JR. Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. International Journal of Pharmaceutics. 1984;19(2):107–27.
40. Veuillez F, Kalia Y, Jacques Y, Deshusses J, Buri P. Factors and strategies for improving buccal absorption of peptides. European Journal of Pharmaceutics and Biopharmaceutics. 2001;51(2):93–109.
41. Awasthi R, Kulkarni GT. Development of Novel Gastroretentive Floating Particulate Drug Delivery System of Gliclazide. Current Drug Delivery. 2012;9(5):437–51.
42. Patel JK, Patel RP, Amin AF, Patel MM. Formulation and evaluation of mucoadhesive glipizide microspheres. AAPS PharmSciTech. 2005;6(1): E49–55.
43. D P, Yanmanagandla D, Sripada RD. Formulation and Evaluation Of Linagliptin Mucoadhesive Microspheres. International Research Journal Of Pharmacy. 2018;9(5):11–7.
44. Sarkar D, Nandi G, Changder A, Hudati P, Sarkar S, Ghosh LK. Sustained release gastroretentive tablet of metformin hydrochloride based on poly (acrylic acid)-grafted-gellan. International Journal of Biological Macromolecules. 2017;96:137–48.
45. Sonar GS, Jain DK, More DM. Preparation and in vitro evaluation of bilayer and floating-bioadhesive tablets of rosiglitazone maleate. Asian Journal of Pharmaceutical Sciences. 2007;2(4):161–9.
46. Sah SK, Tiwari A, Shrivastava B. Formulation Optimization and In-Vivo evaluation of Floating Gastroretentive Microsphere of Sitagliptin by 32 Factorial Design. International Journal of Pharmaceutical Sciences Review and Research. 2016;40(2):198–206.
47. Prajapati VD, Jani GK, Khutliwala TA, Zala BS. Raft forming system—An upcoming approach of gastroretentive drug delivery system. Journal of Controlled Release. 2013;168(2):151–65.
48. Foster KA, Sun H, Fancher RM, Proszynski M, Dixon G, Ford K, et al. Utility of Gastric-Retained Alginate Gels to Modulate Pharmacokinetic Profiles in Rats. Journal of Pharmaceutical Sciences. 2013;102(8):2440–9.
49. Senjoti FG, Mahmood S, Jaffri JM, Mandal UK. Design and In-vitro Evaluation of Sustained Release Floating Tablets of Metformin HCl Based on Effervescence and Swelling. Iranian Journal of Pharmaceutical Research. 2016;15(1):53–70.
50. Mahmoud DB, Shukr MH, Elmeshad AN. Gastroretentive Cosolvent-Based In Situ Gel as a Promising Approach for Simultaneous Extended Delivery and Enhanced Bioavailability of Mitiglinide Calcium. Journal of Pharmaceutical Sciences. 2019;108(2):897–906.
51. Chen J, Park K. Synthesis and characterization of superporous hydrogel composites. Journal of Controlled Release. 2000;65(1-2):73–82.
52. Park H, Park K, Kim D. Preparation and swelling behavior of chitosan-based superporous hydrogels for gastric retention application. Journal of Biomedical Materials Research Part A. 2006;76A(1):144–50.
53. Gupta N, Shivakumar H. Preparation and Characterization of Superporous Hydrogels as pH-Sensitive Drug Delivery System for Pantoprazole Sodium. Current Drug Delivery. 2009;6(5):505–10.
54. Kumar M, Kaushik D. An Overview on Various Approaches and Recent Patents on Gastroretentive Drug Delivery Systems. Recent Patents on Drug Delivery and Formulation. 2018;12(2):84–92.
55. Angelopoulou A, Voulgari E, Kolokithas-Ntoukas A, Bakandritsos A, Avgoustakis K. Magnetic Nanoparticles for the Delivery of Dapagliflozin to Hypoxic Tumors: Physicochemical Characterization and Cell Studies. AAPS PharmSciTech. 2017;19(2):621–33.